Deepfakes impersonate doctors to sell unregulated treatments
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Deepfakes are being used to impersonate specific physicians in AI-generated videos that promote over-the-counter hormone supplements, with investigations confirming these synthetic endorsements appear on major platforms.
- Clinicians face a dual threat: patients may be misled by fake medical advice featuring their likeness, and the 'liar’s dividend' allows those who made real harmful statements to dismiss them as forgeries.
- Electronic health records risk becoming unreliable as deepfake audio, video, and manipulated medical images could infiltrate clinical workflows, including telehealth visits and diagnostic documentation.
- Generative AI tools can fabricate synthetic clinical datasets and research findings, raising concerns that bad actors could generate fake trials with realistic tables, figures, and patient data to support false claims.
- National Institute of Standards and Technology advocates for layered trust infrastructure, including provenance tracking, watermarking, detection, and auditing, because no single method can fully secure medical authenticity.
- Health systems can adopt near-term safeguards such as verified channels for clinical communication, callback verification for high-risk orders, tamper-evident provenance for diagnostic media, and one-click reporting for suspected synthetic content.
- Federal Trade Commission has existing authority to act against deceptive advertising when deepfakes use a clinician’s identity without consent, and journals should tighten disclosure rules for synthetic data in research.
Why it matters: Patients and clinicians lose the foundational trust needed for safe care when digital authenticity can’t be assumed. Without verification norms, a single deepfake can trigger medication errors, erode accountability, and pollute medical literature—risks that scale faster than detection efforts.
